The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Patel Sushil since 2022.
This trader's CIK number is 1860609.
At the time of last reporting, Patel Sushil was the Chief Executive Officer of Replimune Group, Inc.. (stock ticker symbol REPL).
Also see all insider trading activities at Replimune Group, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RVMD | 0 | $0 | 9,310 | $445,270 | 9,310 | $196,608 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | REPL | 0 | $0 | 25,105 | $202,346 | 0 | $0 |
| 2024 | REPL | 0 | $0 | 30,194 | $254,855 | 0 | $0 |
| 2023 | REPL | 0 | $0 | 21,273 | $416,597 | 0 | $0 |
| 2022 | REPL | 0 | $0 | 10,687 | $155,923 | 0 | $0 |
1. Revolution Medicines, Inc. (RVMD)
2. Replimune Group, Inc. (REPL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-31 | RVMD | Option Ex | 5,000 | 24.84 | 124,200 |
| 2024-10-31 | RVMD | Sale | 5,000 | 54.14 | 270,715 |
| 2024-07-09 | RVMD | Option Ex | 2,155 | 16.80 | 36,204 |
| 2024-07-09 | RVMD | Sale | 2,155 | 44.00 | 94,820 |
| 2024-04-10 | RVMD | Option Ex | 2,155 | 16.80 | 36,204 |
| 2024-04-10 | RVMD | Sale | 2,155 | 37.00 | 79,735 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-20 | REPL | Sale | 25,105 | 8.06 | 202,346 |
| 2024-12-16 | REPL | Sale | 10,000 | 12.42 | 124,200 |
| 2024-05-16 | REPL | Sale | 20,194 | 6.47 | 130,655 |
| 2023-06-13 | REPL | Sale | 5,698 | 23.77 | 135,469 |
| 2023-05-16 | REPL | Sale | 15,575 | 18.05 | 281,128 |
| 2022-05-16 | REPL | Sale | 10,687 | 14.59 | 155,923 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Sushil (Chief Executive Officer of Replimune Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.